Effects of Radial Extracorporeal Shock Wave and Kinesio Taping Treatments in Patients with Carpal Tunnel Syndrome

February 22, 2025 updated by: Selda Çiftci, Sisli Hamidiye Etfal Training and Research Hospital

Effects of Radial Extracorporeal Shock Wave and Kinesio Taping Treatments on Quality of Life, Hand Function and Median Nerve Cross-Sectional Area Measured by Ultrasonography in Patients with Carpal Tunnel Syndrome: a Single-Blind Randomized Controlled Trial

Carpal Tunnel Syndrome (CTS) is a common upper extremity nerve compression syndrome that causes significant economic and social burden to affected individuals. Although the severity may vary among patients, symptoms such as night pain, transient numbness, tingling, constant pain, muscle weakness, and sleep disturbance may be observed. The treatment of CTS can be grouped as nonsurgical and surgical treatments. The aim of this study is to investigate the effects of treatment with sound waves and a healing method called extracorporeal shock wave therapy and a therapeutic flexible tape called kinesiology taping on pain, grip strength, quality of life, depression symptoms, hand functions, and ultrasonographic median nerve cross-sectional area in patients with CTS.

Study Overview

Detailed Description

Carpal tunnel syndrome is the most common nerve entrapment syndrome, typically affecting the dominant extremity. Symptoms often become more pronounced at night, and may include numbness, tingling, electric shock sensations, pain, and other related symptoms. Diagnosis can be made based on patient history, physical examination, electrodiagnostic tests, and ultrasonography. Treatment options include splinting, exercise therapy, physical therapy modalities, various injections, and surgical methods.

In our study, we compared the effects of extracorporeal shock wave therapy (ESWT) and kinesiology taping (KT) on carpal tunnel syndrome. The study involved four randomized groups: Group 1 received both ESWT and KT, Group 2 received only ESWT, Group 3 received only KT, and Group 4 received exercise therapy alone. Evaluations were conducted using the Visual Analog Scale, Boston Carpal Tunnel Questionnaire, Douleur Neuropathique 4 Questions, Nottingham Health Profile, grip strength measurements, and median nerve cross-sectional area via ultrasonography. Evaluations were performed three times: before treatment, at week 3, and at week 6.

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • İstanbul, Turkey
        • Sisli Hamidiye Etfal Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Mild to moderate unilateral carpal tunnel syndrome confirmed by electroneuromyography (ENMG)
  • Patients over 18 years of age
  • Symptom duration of at least 3 months
  • Those who have not received any medical treatment other than analgesics in the last 3 months

Exclusion Criteria:

  • Bilateral Carpal Tunnel Syndrome (CTS)
  • Severe CTS detected by ENMG
  • Operated CTS
  • Corticosteroid injection within the last 3 months
  • History of peripheral nerve damage
  • Secondary CTS causes (thyroid dysfunction, connective tissue diseases)
  • Cervical disc herniation
  • DeQuervain tenosynovitis, trigger finger, Dupuytren contracture
  • Inflammatory disorder
  • Bleeding disorder
  • Pregnancy
  • Malignancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 1
Those who received both extracorporeal shock wave therapy (ESWT) and kinesio taping (KB)
Radial ESWT (Vibrolith OrthoⓇ) was applied to the wrist as 1000 pulses with a frequency of 5 Hz and a power of 1.5 bar. The treatment was applied once a week for a total of 3 sessions.
KT was prepared as 2 pieces of 2.5 cm I band and 1 piece of 5 cm I band. It was applied with a maximum of 50% tension (without tension on the ends) while the wrist was in 30 degrees of extension, forearm supination and elbow extension. The treatment was applied once a week for a total of 3 sessions.
Median nerve gliding exercises were given to the 4th group during the follow-up period. The same exercises were given to the other groups.
Active Comparator: Group 2
Those who received ESWT
Radial ESWT (Vibrolith OrthoⓇ) was applied to the wrist as 1000 pulses with a frequency of 5 Hz and a power of 1.5 bar. The treatment was applied once a week for a total of 3 sessions.
Median nerve gliding exercises were given to the 4th group during the follow-up period. The same exercises were given to the other groups.
Active Comparator: Group 3
Those who received KT
KT was prepared as 2 pieces of 2.5 cm I band and 1 piece of 5 cm I band. It was applied with a maximum of 50% tension (without tension on the ends) while the wrist was in 30 degrees of extension, forearm supination and elbow extension. The treatment was applied once a week for a total of 3 sessions.
Median nerve gliding exercises were given to the 4th group during the follow-up period. The same exercises were given to the other groups.
Other: Group 4
Those who received only exercise
Median nerve gliding exercises were given to the 4th group during the follow-up period. The same exercises were given to the other groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain level before treatment, 3rd week and 6th week after treatment
Time Frame: From enrollment to the end of treatment at 3rd week and 6th week
Pain level will be evaluated with the Visual Analog Scale. (minimum: 0, maximum: 100 mm)
From enrollment to the end of treatment at 3rd week and 6th week
Assessment of symptom severity and functionality
Time Frame: From enrollment to the end of treatment at 3rd week and 6th week
The Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) questionnaire was used to assess symptom severity and functionality. It includes 2 subgroups: Symptom Severity Scale (SSS) and Functional Status Scale (FSS). Symptom severity is assessed with 11 questions, and functional status is assessed with 8 questions. Each question is scored from low to high, 1 to 5. As the total score increases, deterioration increases.
From enrollment to the end of treatment at 3rd week and 6th week
Assessment of median nerve cross sectional area by ultrasonography
Time Frame: From enrollment to the end of treatment at 3rd week and 6th week
The median nerve cross-sectional area was measured by tracing just proximal to the carpal tunnel entrance with the wrist resting on a table in a neutral position. The carpal tunnel entrance was identified by detecting the proximal side of the transverse carpal ligament. The distal radioulnar joint was also observed at this level.
From enrollment to the end of treatment at 3rd week and 6th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of grip strength and lateral pinch strength
Time Frame: From enrollment to the end of treatment at 3rd week and 6th week
A hydraulic hand dynamometer was used to assess grip strength, and a hydraulic pinchmeter was used to assess lateral pinch strength. Measurements were made using the 2nd level resistance (3.75 cm) with the elbow at 90 degrees of flexion and the forearm and wrist in a neutral position. Patients were asked to squeeze with maximum force, measurements were made three times, and the average result was recorded in kilograms. For lateral pinch (LP), the pinchmeter was pressed with the distal middle of the thumb, and the lateral part of the second phalanx of the index finger was used to support the lower part.
From enrollment to the end of treatment at 3rd week and 6th week
Assessment of functionality
Time Frame: From enrollment to the end of treatment at 3rd week and 6th week
Duruöz Hand Index was used for functional assessment. This questionnaire contains 18 questions on hand activities. It consists of five areas. There are eight questions on kitchen activities, two questions on dressing, two questions on personal hygiene, two questions on office work and four questions on other activities. The patient selects one of the answers for each question on a scale of one to five. The scores given for each question are added to obtain a total score ranging from 0 to 90. Higher scores indicate more severe hand disability.
From enrollment to the end of treatment at 3rd week and 6th week
Assessment of neuropathic pain
Time Frame: From enrollment to the end of treatment at 3rd week and 6th week
Douleur Neuropathique 4 Questions was used to assessment of neuropathic pain. The DN4 questionnaire consists of 10 items. The first 7 items are related to pain characteristics and sensation, while the remaining 3 items are related to examination. For each item, a score of "1" is given if the answer is "yes" and a score of "0" if the answer is "no". If the total number of yes answers from the 10 items is calculated as 4 or more, the patient is defined as having neuropathic pain.
From enrollment to the end of treatment at 3rd week and 6th week
Assessment of quality of life
Time Frame: From enrollment to the end of treatment at 3rd week and 6th week
The Nottingham Health Profile was used.As a general health status questionnaire, it provides a brief indication of a patient's perceived emotional, social and physical health and is designed for use in the general population. It is concerned with the individual's health status and includes energy levels, pain, emotional responses, sleep, social isolation and physical abilities. The energy levels domain consists of 3 items, pain 8 items, emotional responses 9 items, sleep and social isolation domains 5 items each and physical abilities domain 8 items. Each item requires a yes or no response. The patient's score is calculated out of a total of 600 points. The higher the score, the lower the quality of life.
From enrollment to the end of treatment at 3rd week and 6th week
Assessment of depression
Time Frame: From enrollment to the end of treatment at 3rd week and 6th week
Beck Depression Inventory was used for depression assessment. It consists of 21 items with four precursors scored between 0 and 3. Patients are asked to mark the item that best suits their mood in the past week. As the score increases, it is thought that the depressive state is more severe. The total score is scored as 0-9 = Minimal, 10-16 = mild, 17-29 = moderate, 30-63 = severe.
From enrollment to the end of treatment at 3rd week and 6th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Banu Kuran, Professor, MD, Şişli Hamidiye Etfal Training and Research Hospital, Deparment of Physical Medicine and Rehabilitation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2023

Primary Completion (Actual)

March 30, 2024

Study Completion (Actual)

March 30, 2024

Study Registration Dates

First Submitted

February 22, 2025

First Submitted That Met QC Criteria

February 22, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 22, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome (CTS)

Clinical Trials on Extracorporeal shock wave therapy (ESWT)

Subscribe